Who is sponsoring NCT02477930?

NCT02477930 is sponsored by Baylor Research Institute.

What drugs are being tested in NCT02477930?

Interventions in NCT02477930: No interventions are done.

What condition does NCT02477930 study?

NCT02477930 studies Intestinal Anastomotic Leak, Intestinal Perforations.

Is NCT02477930 still recruiting?

NCT02477930 is currently completed. Last updated 25 May 2025.

Last reviewed 2025-05-25 · How we verify

NCT02477930

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Endosponge Vacuum Therapy (E-VAC) Registry of Intestinal Anastomotic Leaks and Perforations

Completed Last updated 25 May 2025

What this trial tests

trial testing No interventions are done in Intestinal Anastomotic Leak in 65 participants. Completed in 21 September 2023.

Timeline

1 November 2014

Primary endpoint
21 September 2023

21 September 2023

Quick facts

Lead sponsor	Baylor Research Institute
Status	Completed
Study type	OBSERVATIONAL
Enrollment	65
Start date	1 November 2014
Primary completion	21 September 2023
Estimated completion	21 September 2023
Sites	1 location across United States

Drugs / interventions tested

No interventions are done

Conditions studied

Intestinal Anastomotic Leak — all drugs for Intestinal Anastomotic Leak →
Intestinal Perforations — all drugs for Intestinal Perforations →

Sponsor

Baylor Research Institute

Who can join

18 and older, any sex, with Intestinal Anastomotic Leak or Intestinal Perforations. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this registry is to collect data on the clinical use of endoluminal vacuum (E-Vac) therapy to treat both upper and lower intestinal leaks and perforations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Baylor Research Institute trials

Trials by the same sponsor.

NCT07467720 — Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial · NA · not yet recruiting
NCT07547878 — Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) · Phase 4 · not yet recruiting
NCT07460583 — ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes · NA · not yet recruiting
NCT07096544 — CALM Study: Cardiomems Assisted Lvad Management · NA · not yet recruiting
NCT07220395 — eHealth Literacy Intervention for Spanish Speaking Older Adults in the US · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02477930 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Baylor Research Institute
Last refreshed: 25 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02477930.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing